Clinical Trial Update: A Study of a New Chemotherapy Agent in Combination With Cisplatin to Treat Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating a new chemotherapy agent in combination with cisplatin for small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Investigational chemotherapy agent (unnamed)

Snippet

Sponsor: Bayer | Conditions: Carcinoma, Small Cell | Phase 1, Phase 2 | Status: COMPLETED